Quick Takeaways
- Kevin F. Mclaughlin has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $648,365.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Kevin F. Mclaughlin
- Location
- Cambridge, MI
- Summary
- The estimated net worth of Kevin F. Mclaughlin is at least $648,365 dollars as of 13 Feb 2026. Kevin F. Mclaughlin is the Director of Vericel Corp and owns shares of Vericel Corp (VCEL) stock worth about $523.4K. Kevin F. Mclaughlin is the Director of Invivyd, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $125K.
- Signature
- /s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Kevin F. Mclaughlin and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Vericel Corp ($523,365).
- Past-year value change for that position: -$1,044,050.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Kevin F. Mclaughlin
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VCEL | Vericel Corp | Director | $523,365 | -$1,044,050 | -67% | 11 Feb 2026 |
| IVVD | Invivyd, Inc. | Director | $125,000 | +$125,000 | +100% | 19 Nov 2025 |
| XLRN | ACCELERON PHARMA INC | SVP, CFO and Treasurer | 19 Nov 2021 | |||
| DBTX | Decibel Therapeutics, Inc. | Director | 25 Sep 2023 |
Insider Transactions Reported by Kevin F. Mclaughlin:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.